工程mRNA疫苗具有针对SARS-cov-2变种的宽频保护
Shuang Du1, Liu Yang2, Xingguang Chen2
1Shenzhen Shenxin Biotechnology Co., Ltd., 518052, China.
Biochemical and biophysical research communications
|January 1, 2025
概括
新的信使RNA疫苗针对多个SARS-CoV-2变种,如Delta和Omicron,提供广泛的保护. 这种新的疫苗方法,mPANVAX@COVID,显示了未来传染病预防的希望.
科学领域:
- 疫苗学 疫苗学 疫苗学
- 病毒学 病毒学
- 分子生物学分子生物学
背景情况:
- 通过疫苗接种获得群体免疫对于控制传染病至关重要.
- 目前的COVID-19疫苗因SARS-CoV-2变种免疫逃避而面临挑战.
- 在SARS-CoV-2变种中频繁发生的突变减少了疫苗诱导的保护.
研究的目的:
- 设计一种疫苗,对多种SARS-CoV-2变种产生广泛的免疫力.
- 开发一种信使RNA (mRNA) 疫苗,对保存的突变表位进行编码.
- 评估新型候选疫苗的安全性和有效性.
主要方法:
- 设计的mRNA编码突变的尖端蛋白质表位,这种表位在SARS-CoV-2变种中很常见.
- 在脂质纳米颗粒中封装的mRNAs创建mPANVAX@COVID疫苗.
- 评估疫苗接种后的免疫反应和对多种变异的保护.
主要成果:
- 该mPANVAX@COVID疫苗诱导了针对SARS-CoV-2变种的有效免疫力.
- 证明了对Delta和Omicron变种的保护.
- 这种候选疫苗表现出良好的安全性.
结论:
- 针对保存变异表位的信使RNA疫苗提供了一个有希望的策略.
- mPANVAX@COVID提供了针对各种SARS-CoV-2菌株的广泛保护.
- 这种方法代表了开发广泛保护性疫苗的新方向.
更多相关视频
10:16Efficient Transfection of In vitro Transcribed mRNA in Cultured Cells Using Peptide-Poloxamine Nanoparticles
Published on: August 17, 2022
3.2K
00:10Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.5K
相关概念视频
Microorganisms in Medicine and Therapeutics
Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Cross-reactivity
31.0K
Overview
31.0K
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
